Analysis of the Consortium of Rheumatology Researchers of North America (CORRONA) registry uncovered a significant trend towards reduced CV events with declining disease activity, even after adjusting for immunomodulatory agents [ 53 ].
1
—
—
Analysis of the Consortium of Rheumatology Researchers of North America (CORRONA) registry uncovered a significant trend towards reduced CV events with declining disease activity, even after adjusting for immunomodulatory agents [ 53 ].